Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMBT
801
CMB.TECH NV
CMBT
$4.47B
| $18.5M | 0.01% |
1,990,822
| – | – |
|
802
Ralph Lauren
RL
$22.5B
| $18.5M | 0.01% |
157,098
+83,108
| +112% | +$10.4M |
|
803
Hydrofarm Holdings
HYFM
$3.17M
| $18.5M | 0.01% |
31,245
-1,164
| -4% | -$685K |
|
804
Celanese
CE
$4.77B
| $18.4M | 0.01% |
121,572
+72,873
| +150% | +$11.6M |
|
805
Ulta Beauty
ULTA
$21.6B
| $18.4M | 0.01% |
53,232
-20,951
| -28% | -$6.87M |
|
806
Norfolk Southern
NSC
$76.1B
| $18.4M | 0.01% |
69,253
-291
| -0.4% | -$80.3K |
|
807
PVH
PVH
$4.01B
| $18.2M | 0.01% |
+169,614
| New | +$18.6M |
|
808
BorgWarner
BWA
$13B
| $18.2M | 0.01% |
426,517
+337,760
| +381% | +$14.9M |
|
809
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.69B
| $18.1M | 0.01% |
+310,289
| New | +$18.4M |
|
810
Brookfield
BN
$104B
| $18.1M | 0.01% |
659,172
+4,282
| +0.7% | +$110K |
|
811
NorthWestern Energy
NWE
$4.45B
| $18.1M | 0.01% |
300,946
-264,505
| -47% | -$17.2M |
|
|
TIG
812
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $18M | 0.01% |
+1,196,544
| New | +$19.5M |
|
813
Public Service Enterprise Group
PEG
$39.3B
| $17.9M | 0.01% |
300,001
+147,484
| +97% | +$9.11M |
|
|
NVO
814
Novo Nordisk
NVO
$225B
| $17.9M | 0.01% |
427,036
-4,698
| -1% | -$182K |
|
815
Trip.com Group
TCOM
$28.5B
| $17.9M | 0.01% |
503,761
-10,349
| -2% | -$394K |
|
816
Dow Inc
DOW
$20.8B
| $17.7M | 0.01% |
280,308
+88,001
| +46% | +$5.81M |
|
817
Franklin FTSE Japan ETF
FLJP
$3.88B
| $17.7M | 0.01% |
596,103
+80,714
| +16% | +$2.44M |
|
818
Design Therapeutics
DSGN
$741M
| $17.7M | 0.01% |
936,650
-249,986
| -21% | -$6.31M |
|
819
Ventas
VTR
$47.7B
| $17.6M | 0.01% |
308,132
+180,235
| +141% | +$10.1M |
|
820
KKR & Co
KKR
$92.2B
| $17.5M | 0.01% |
296,095
+198,905
| +205% | +$11M |
|
821
Truist Financial
TFC
$64.7B
| $17.5M | 0.01% |
314,495
-108,707
| -26% | -$6.39M |
|
822
Federal Realty Investment Trust
FRT
$10.9B
| $17.4M | 0.01% |
148,676
+142,649
| +2,367% | +$16.2M |
|
823
Shattuck Labs
STTK
$651M
| $17.4M | 0.01% |
600,212
-865,869
| -59% | -$25.3M |
|
|
CCRD
824
DELISTED
CoreCard
CCRD
| $17.4M | 0.01% |
552,463
-20,755
| -4% | -$740K |
|
825
Altria Group
MO
$125B
| $17.1M | 0.01% |
358,312
+24,161
| +7% | +$1.19M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.